Figure 2From: Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib PET-CT scan before (A) and after (B) three months of treatment with erlotinib, showing improvement in the mediastinal lymph node and left lung uptake. Back to article page